HuGE Literature Finder
Records 1-20
|
Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
Brain pathology (Zurich, Switzerland) 2020 Jul . Vaubel Rachael, Zschernack Valentina, Tran Quynh T, Jenkins Sarah, Caron Alissa, Milosevic Dragana, Smadbeck James, Vasmatzis George, Kandels Daniela, Gnekow Astrid, Kramm Christof, Jenkins Robert, Kipp Benjamin R, Rodriguez Fausto J, Orr Brent A, Pietsch Torsten, Giannini Cateri |
|
Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.
Cellular and molecular neurobiology 2020 Jun . Carlos-Escalante José Alberto, Gómez-Flores-Ramos Liliana, Bian Xiaopeng, Perdomo-Pantoja Alexander, de Andrade Kelvin César, Mejía-Pérez Sonia Iliana, Cacho-Díaz Bernardo, González-Barrios Rodrigo, Reynoso-Noverón Nancy, Soto-Reyes Ernesto, Sánchez-Correa Thalía Estefanía, Guerra-Calderas Lissania, Yan Chunhua, Chen Qingrong, Castro-Hernández Clementina, Vidal-Millán Silvia, Taja-Chayeb Lucía, Gutiérrez Olga, Álvarez-Gómez Rosa María, Gómez-Amador Juan Luis, Ostrosky-Wegman Patricia, Mohar-Betancourt Alejandro, Herrera-Montalvo Luis Alonso, Corona Teresa, Meerzaman Daoud, Wegman-Ostrosky Tal |
|
Germline cancer predisposition variants and pediatric glioma: a population-based study in California.
Neuro-oncology 2020 Jan . Muskens Ivo S, de Smith Adam J, Zhang Chenan, Hansen Helen M, Morimoto Libby, Metayer Catherine, Ma Xiaomei, Walsh Kyle M, Wiemels Joseph |
|
von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.
Brain tumor research and treatment 2019 Apr 7 (1): 33-38. Lehrer Steven, Rheinstein Peter H, Green Sheryl, Rosenzweig Kenneth |
|
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.
Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
|
TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.
Oncotarget 2016 Jun . Mascelli Samantha, Nozza Paolo, Jones David T W, Colin Carole, Pistorio Angela, Milanaccio Claudia, Ravegnani Marcello, Consales Alessandro, Witt Olaf, Morana Giovanni, Cama Armando, Capra Valeria, Biassoni Roberto, Pfister Stefan M, Figarella-Branger Dominique, Garrè Maria Luisa, Raso Alessand |
|
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
Acta neuropathologica communications 2016 4 (1): 1. Hoffman Lindsey M, DeWire Mariko, Ryall Scott, Buczkowicz Pawel, Leach James, Miles Lili, Ramani Arun, Brudno Michael, Kumar Shiva Senthil, Drissi Rachid, Dexheimer Phillip, Salloum Ralph, Chow Lionel, Hummel Trent, Stevenson Charles, Lu Q Richard, Jones Blaise, Witte David, Aronow Bruce, Hawkins Cynthia E, Fouladi Mary |
|
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
|
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
|
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2898-909. Wakimoto Hiroaki, Tanaka Shota, Curry William T, Loebel Franziska, Zhao Dan, Tateishi Kensuke, Chen Juxiang, Klofas Lindsay K, Lelic Nina, Kim James C, Dias-Santagata Dora, Ellisen Leif W, Borger Darrell R, Fendt Sarah-Maria, Vander Heiden Matthew G, Batchelor Tracy T, Iafrate A John, Cahill Daniel P, Chi Andrew |
|
Molecular markers in low-grade gliomas: predictive or prognostic?
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (13): 4588-99. Hartmann Christian, Hentschel Bettina, Tatagiba Marcos, Schramm Johannes, Schnell Oliver, Seidel Clemens, Stein Robert, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Loeffler Markus, Weller Michael, |
|
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.
Neuro-oncology 2011 Feb 13 (2): 235-41. Taal Walter, Dubbink Hendrikus J, Zonnenberg Chris B L, Zonnenberg Bernard A, Postma Tjeerd J, Gijtenbeek Johanna M M, Boogerd Willem, Groenendijk Floris H, Kros Johan M, Kouwenhoven Mathilde C M, van Marion Ronald, van Heuvel Irene, van der Holt Bronno, Bromberg Jacoline E C, Sillevis Smitt Peter A E, Dinjens Winand N M, van den Bent Martin J, |
|
MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.
Journal of neuro-oncology 2011 Feb 101 (3): 405-17. Groenendijk Floris H, Taal Walter, Dubbink Hendrikus J, Haarloo Cathleen R, Kouwenhoven Mathilde C, van den Bent Martin J, Kros Johan M, Dinjens Winand N |
|
Molecular classification of low-grade diffuse gliomas.
The American journal of pathology 2010 Dec 177 (6): 2708-14. Kim Young-Ho, Nobusawa Sumihito, Mittelbronn Michel, Paulus Werner, Brokinkel Benjamin, Keyvani Kathy, Sure Ulrich, Wrede Karsten, Nakazato Yoichi, Tanaka Yuko, Vital Anne, Mariani Luigi, Stawski Robert, Watanabe Takuya, De Girolami Umberto, Kleihues Paul, Ohgaki Hiro |
|
p53 abnormality and tumor invasion in patients with malignant astrocytoma.
Brain tumor pathology 2010 Oct 27 (2): 95-101. Momota Hiroyuki, Narita Yoshitaka, Matsushita Yuko, Miyakita Yasuji, Shibui Soichi |
|
Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.
Journal of neuro-oncology 2010 Sep 99 (2): 209-15. Antonelli Manila, Buttarelli Francesca Romana, Arcella Antonietta, Nobusawa Sumihito, Donofrio Vittoria, Oghaki Hiroko, Giangaspero Feli |
|
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.
The American journal of pathology 2009 Apr 174 (4): 1149-53. Watanabe Takuya, Nobusawa Sumihito, Kleihues Paul, Ohgaki Hiro |
|
Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
Journal of neuropathology and experimental neurology 2009 Feb 68 (2): 210-5. Watanabe Takuya, Nobusawa Sumihito, Lu Shengqing, Huang Jian, Mittelbronn Michel, Ohgaki Hiro |
|
Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Jul 14 (7): 1774-83. Wiencke John K, Aldape Kenneth, McMillan Alex, Wiemels Joe, Moghadassi Michelle, Miike Rei, Kelsey Karl T, Patoka Joe, Long Jeff, Wrensch Margar |
|
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1.
Neuro-oncology advances 0 2 (1): vdaa042. Alghamri Mahmoud S, Thalla Rohit, Avvari Ruthvik P, Dabaja Ali, Taher Ayman, Zhao Lili, Ulintz Peter J, Castro Maria G, Lowenstein Pedro |
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 23, 2021
- Content source: